Celltech Chiroscience Limited
Records under this name other than patents Celltech Chiroscience Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Celltech Chiroscience Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,808,901 | Production of chimeric antibodies Formerly held In force Term ended Oct 26, 2026 · From the USPTO record | In force | Term ended Oct 26, 2026 | From the USPTO record |
| US 7,012,135 | Biological Products Formerly held Term ended Term ended Feb 13, 2024 · High confidence | Term ended | Term ended Feb 13, 2024 | High confidence |
| US 7,186,820 | Production of Humunised Antibodies to Tnf-Alpha Formerly held Term ended Term ended Feb 3, 2022 · High confidence | Term ended | Term ended Feb 3, 2022 | High confidence |
| US 7,402,662 | Antibody Molecules Specific to Human Tumor Necrosis Factor Alpha Formerly held Term ended Term ended Nov 24, 2021 · High confidence | Term ended | Term ended Nov 24, 2021 | High confidence |
| US 7,977,464 | Antibody Molecules Specific to Human Tumour Necrosis Factor Alpha Formerly held Term ended Term ended Nov 24, 2021 · High confidence | Term ended | Term ended Nov 24, 2021 | High confidence |
| US 7,566,771 | Humanised antibodies Formerly held Surrendered on reissue Surrendered on reissue Oct 26, 2021 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Oct 26, 2021 | From the USPTO record |
| US 6,316,227 | Nucleic acids encoding interleukin-5 specific recombinant antibodies Formerly held Term ended Term ended Jul 2, 2019 · From the USPTO record | Term ended | Term ended Jul 2, 2019 | From the USPTO record |
| US 8,067,005 | Divalent antibody fragments Formerly held Term ended Term ended Jun 8, 2019 · From the USPTO record | Term ended | Term ended Jun 8, 2019 | From the USPTO record |
| US 6,734,286 | INTERLEUKIN-5 Specific Recombinant Antibodies Formerly held Term ended Ended no later than Jun 6, 2015 · Low confidence | Term ended | Ended no later than Jun 6, 2015 | Low confidence |
| US RE39,548 | INTERLEUKIN-5 Specific Recombinant Antibodies Formerly held Term ended Term ended Jun 6, 2015 · Low confidence | Term ended | Term ended Jun 6, 2015 | Low confidence |